🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Adjuvanted, trivalent subunit influenza vaccine

Found 15 matching trials

Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, Including MF59C.1 Adjuvant, in Healthy Adults ≥65 Years of Age

PHASE2

The present study is designed to confirm the safety and immunogenicity of t...

Status

Completed

Location

Antwerp University Centre for the Evaluation of Vaccination

Start Date

2013-07

Trial ID

NCT01879540

Treatments Being Tested

aTIV

Comparison of the Cellular and the Humoral Immunogenicity, Safety of Different Trivalent Influenza Vaccines

PHASE4

This is a randomized, single-blinded, Phase IV, monocentric study in health...

Status

Unknown

Location

National Health Centre

Start Date

2008-11

Trial ID

NCT01119157

Treatments Being Tested

influenza vaccine

A Post-marketing Study to Monitor the Safety of a MF59-adjuvanted Influenza Vaccine Administered in Korean Subjects Aged 65 Years or Older

PHASE4

This study will evaluate the safety of an influenza (flu) vaccine in Korean...

Status

Completed

Location

KeeTaek Kim internal medicine Clinic

Start Date

2010-10

Trial ID

NCT01222403

Treatments Being Tested

Fluad_MF59-adjuvanted trivalent influenza subunit vaccine Vantaflu_MF59-adjuvanted trivalent influenza subunit vaccine

Phase 3 Safety and Immunogenicity Study of aQIV in Elderly Adults

PHASE3

This phase 3 study is a randomized, double-blinded, comparator controlled, ...

Status

Completed

Location

Coastal Clinical Research, Inc.

Start Date

2017-10-17

Trial ID

NCT03314662

Treatments Being Tested

MF59-adjuvanted Quadrivalent Subunit Inactivated Egg-derived Influenza Vaccine (aQIV)Licensed MF59-adjuvanted Trivalent Subunit Inactivated Egg-derived Influenza Vaccine (aTIV-1)MF59-adjuvanted Trivalent Subunit Inactivated Egg-derived Influenza Vaccine Containing the Alternate B Strain (aTIV-2)

Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2010-2011

PHASE2

This study will evaluate the safety and immunogenicity of a sub-unit, adjuv...

Status

Completed

Location

Dipartimento di Medicina e Scienze dell'Invecchiamento, Università G. D'Annunzio, Via dei Vestini

Start Date

2010-06

Trial ID

NCT01152814

Treatments Being Tested

Seasonal flu vaccine

Placebo Controlled Study to Generate Data Characterising Clinical Events, Physiological Responses and Immune Responses

PHASE4

The purpose of this protocol is to generate a set of data that will be anal...

Status

Completed

Location

Center for Vaccinology

Start Date

2014-10-02

Trial ID

NCT02523287

Treatments Being Tested

Fluad Saline

Safety and Immunogenicity of Different Formulations of an Adjuvanted, Trivalent Subunit Influenza Vaccine in Elderly Subjects 65 Years of Age and Above

PHASE1

In this study, the safety and immunogenicity of the current formulation of ...

Status

Completed

Location

PAREXEL Early Phase Clinical Unit

Start Date

2014-06

Trial ID

NCT02126761

Treatments Being Tested

Adjuvanted, trivalent subunit influenza vaccine Adjuvant level modified adjuvanted, trivalent subunit influenza vaccine Antigen level modified adjuvanted, trivalent subunit influenza vaccine Antigen and adjuvant level modified adjuvanted, trivalent subunit influenza vaccine

Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.

PHASE2

This phase II, open label, is designed as a seasonal study to support annua...

Status

Completed

Location

Azienda Sanitaria USL 7 di Siena

Start Date

2007-06

Trial ID

NCT00522067

Treatments Being Tested

Adjuvanted influenza vaccine

Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.

PHASE3

Safety, Immunogenicity and Efficacy of an Adjuvanted Quadrivalent Subunit I...

Status

Completed

Location

222, Novartis Investigational Site

Start Date

2013-11

Trial ID

NCT01964989

Treatments Being Tested

Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV)Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV)

Comparison of 4 Influenza Vaccines in Seniors

PHASE4

Based on information from several years of looking at Influenza vaccination...

Status

Completed

Location

University of British Columbia, VITALiTY Research Center

Start Date

2011-07

Trial ID

NCT01368796

Treatments Being Tested

Agriflu Fluad Intanza Vaxigrip

Previous Next